AnalystsStan BerenshteynStan Berenshteyn's Stock Forecasts
AnalystsStan Berenshteyn
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4955 out of 5154 analysts
Average Return
-5.06%
Win Rate
48%20 out of 42
Risk vs Reward
Poor
Good
Stan Berenshteyn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Omnicell IncOMCL | +59.61% | $28.03 | $44.74 | 2025-07-20 - 2025-12-16 | Strong Buy |
Omnicell IncOMCL | +58.48% | $28.23 | $44.74 | 2025-05-22 - 2025-12-16 | Strong Buy |
Omnicell IncOMCL | +55.73% | $28.73 | $44.74 | 2025-05-13 - 2025-12-16 | Strong Buy |
Accolade IncACCD | +53.41% | $13.80 | $6.43 | 2022-04-10 - 2022-05-02 | Strong Sell |
Omnicell IncOMCL | +51.58% | $62.87 | $30.44 | 2023-07-19 - 2023-11-03 | Strong Sell |
Stan Berenshteyn Analyst Color
Get additional color on Stan Berenshteyn's coverage of popular stocks
Stan Berenshteyn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Veeva Systems IncVEEV | 9 | Strong Buy | $333.00 | +51.85% | Maintains | 22 days ago |
Health Catalyst IncHCAT | 7 | Strong Buy | $5.00 | +104.92% | Maintains | a month ago |
American Well CorpAMWL | 5 | Strong Buy | $9.00 | +91.49% | Maintains | a month ago |
Doximity IncDOCS | 12 | Hold | $65.00 | +48.40% | Maintains | 4 months ago |
Omnicell IncOMCL | 17 | Strong Buy | $40.00 | -10.59% | Maintains | 5 months ago |
Teladoc Health IncTDOC | 3 | Hold | $8.00 | +7.96% | Maintains | 7 months ago |
Goodrx Holdings IncGDRX | 8 | Strong Buy | $7.00 | +153.62% | Maintains | 8 months ago |
Healthequity IncHQY | 9 | Strong Buy | $125.00 | +30.21% | Maintains | 10 months ago |
Accolade IncACCD | 10 | Hold | $6.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.